ALPS Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $768K | Sell |
|
|||||
|
2025
Q2 | $1.01M | Sell |
|
|||||
|
2025
Q1 | $1.15M | Sell |
|
|||||
|
2024
Q4 | $1.26M | Buy |
|
|||||
|
2024
Q3 | $1.2M | Sell |
|
|||||
|
2024
Q2 | $995K | Buy |
|
|||||
|
2024
Q1 | $739K | Buy |
|
|||||
|
2023
Q4 | $827K | Sell |
|
|||||
|
2023
Q3 | $990K | Buy |
|
|||||
|
2023
Q2 | $978K | Buy |
|
|||||
|
2023
Q1 | $1.02M | Sell |
|
|||||
|
2022
Q4 | $1.45M | Buy |
|
|||||
|
2022
Q3 | $1.28M | Sell |
|
|||||
|
2022
Q2 | $1.17M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $630K | Buy |
|
|||||
|
2017
Q4 | $535K | Buy |
|
|||||
|
2017
Q3 | $415K | Buy |
|
|||||
|
2017
Q2 | $404K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $233K | Sell |
|
|||||
|
2015
Q4 | $997K | Buy |
|